Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma-Reference-Cited by-同舟云学术

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Published:2017-11-23 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Lauss Martin,Donia Marco,Harbst Katja,Andersen Rikke,Mitra Shamik,Rosengren Frida,Salim Maryem,Vallon-Christersson Johan^ORCID,Törngren Therese,Kvist Anders^ORCID,Ringnér Markus^ORCID,Svane Inge Marie,Jönsson Göran

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01460-0.pdf

Reference58 articles.

1. Svane, I. M. & Verdegaal, E. M. Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care? Cancer Immunol. Immunother. 63, 1081–1091 (2014).

2. Radvanyi, L. G. et al. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin. Cancer Res. 18, 6758–6770 (2012).

3. Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550–4557 (2011).

4. Besser, M. J. et al. Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies. Clin. Cancer Res. 19, 4792–4800 (2013).

5. Besser, M. J. et al. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin. Cancer Res. 16, 2646–2655 (2010).

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis;Computational and Structural Biotechnology Journal;2024-12

2. Advances in Vaccines for Melanoma;Hematology/Oncology Clinics of North America;2024-10

3. Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis;Annals of Oncology;2024-10

4. Single-cell profiling uncovers proliferative cells as key determinants of survival outcomes in lower-grade glioma patients;Discover Oncology;2024-09-14

5. Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive Review;Journal of Clinical Medicine;2024-09-12